Supreme Court declines urgent hearing on plea against PM’s chadar offering at Ajmer Dargah
_vb_04.jpeg)
New Delhi: A petition to prevent Prime Minister Narendra Modi from performing a ceremonial chadar at the Ajmer Sharif Dargah during the 814th annual Urs of Sufi saint Khwaja Moinuddin Hasan Chisti was rejected by the Supreme Court for immediate hearing.
The plea was mentioned for urgent listing before a bench headed by Chief Justice of India Surya Kant and Justice Joymalya Bagchi, as reported by Hindustan Times. Making his position clear, the Chief Justice said on Monday that the court would not list any matter on the same day merely on oral mentioning. The bench indicated that if the petition met the required threshold of urgency, it could be considered for listing on a later date, possibly December 26 or December 29.
ALSO READ: Centre rejects claims of diluting Aravalli protections, says 90% of range will remain safeguarded
“No listing today,” the bench said, refusing the request for an immediate hearing. The petition challenges the proposed ceremonial offering at the Ajmer Sharif Dargah. This offering is a tradition that has been followed by successive Prime Ministers since Independence and according to media reports Union Minority Affairs Minister Kiren Rijiju is scheduled to offer the chadar on behalf of the Prime Minister as part of the Urs observances.
During the brief exchange, counsel for the petitioner argued that a similar matter relating to the Sankat Mochan Mandir was already pending before the court.The bench was not convinced that the situation required immediate judicial action when the attorney requested an urgent stay on the chadar offering.
The petition has been filed as a public interest litigation by Jitender Singh, president of the Vishwa Vedic Sanatan Sangh, through advocate Barun Kumar Sinha. It questions what it describes as “state-sponsored ceremonial honours, official patronage and symbolic recognition” extended to Khwaja Moinuddin Chisti by Union government authorities.
The plea contends that such practices are unconstitutional and arbitrary, and claims they run contrary to the constitutional ethos, dignity and sovereignty of the nation. Referring to historical accounts, the petitioner has argued that Chisti arrived in India during the 12th century, around the time of invasions led by Shahabuddin Ghori, and was allegedly linked to foreign conquest and religious conversion, with the institutionalisation of the dargah occurring much later.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
India misses 2025 TB elimination target; cases stand at 185 per 100,000 population
New Delhi: India reported an estimated 2.7 million tuberculosis cases in 2025 which translates into an incidence of 185 cases per 100,000 population, according to the latest official update on the disease burden.
The figure is more than four times the elimination benchmark set under the National Strategic Plan for Tuberculosis. The plan had aimed to bring down incidence to 44 cases per 100,000 population and mortality to three per 100,000 by 2025. The target was announced in March 2017 and was set five years ahead of the global End TB goals and the UN Sustainable Development Goals.
Data indicate that TB notifications have increased by 13 per cent compared to pre-Covid levels, as IndiaSpend reported in July 2025. Public health experts have said higher notification does not necessarily reflect a rise in incidence, but indicate improved case detection. Authorities have stepped up efforts to improve reporting and plug gaps in diagnosis and treatment, under the National Tuberculosis Elimination Programme (NTEP).
According to a 2019 study published in PLOS Medicine, the most substantial gap occurs during the testing stage, with nearly half of those with incident tuberculosis not receiving diagnostic tests. Experts say stigma, restricted availability to molecular testing, and dependence on sputum microscopy continue to impede early detection.
According to official data, 19.3 million smear microscopy tests were performed in 2023, compared to 6.83 million molecular tests using the CBNAAT/GeneXpert and Truenat platforms, indicating that smear-based diagnosis will continue to be used. While doctors report inconsistent implementation across regions, legislation mandates 100% molecular testing for suspected tuberculosis patients.
Health officials point to the increase of diagnostic infrastructure, which includes approximately 10,000 Nucleic Acid Amplification Test equipment and over 25,000 microscopy centers across the country. Eexperts identify operational difficulties such as specimen transportation, machine maintenance, supplier chains, and unequal distribution of skilled staff.
Under the TB-Mukt Bharat Abhiyan, the government has expanded active case-finding in high-risk areas and identified 1.58 lakh vulnerable villages and urban wards using an AI-based mapping tool. Under which the latest campaign document states that of the 2.73 million cases reported in 2025, 35 per cent were asymptomatic.
Specialists warn that up to half of microbiologically diagnosed pulmonary tuberculosis patients may not show characteristic symptoms, contributing to continuous community transmission. To increase early diagnosis of drug resistance, it is advised that chest X-rays and molecular testing be used more frequently.
Specialists warn that up to half of microbiologically diagnosed pulmonary tuberculosis patients may not show characteristic symptoms, contributing to continuous community transmission. To increase early diagnosis of drug resistance, it is advised that chest X-rays and molecular testing be used more frequently.
The government increased financial aid for Tuberculosis patients under the Nikshay Poshan Yojana to ₹1,000 per month, as the disease is mostly linked with malnutrition and poor living conditions and those with a BMI less than 18.5 are given energy-dense nutritional supplements for the first two months of therapy.
